Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774137 · ClinicalTrials.gov registry record
Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 1,550
- Enrollment target
NCT00774137: Completed study, sponsored by Yale University.
NCT00774137 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 1,550 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00774137 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 1,550 participants
- Enrollment target
Study Summary
People who undergo coronary artery bypass grafting (CABG) or heart valve surgery may experience acute kidney injury (AKI) after their surgery. Current medical tests cannot identify AKI until approximately 48 hours after it occurs. This study will examine three new biomarkers in blood and urine that may provide a more effective and faster way of predicting AKI in people who undergo CABG or heart valve surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,550 participants |
| Start Date | 2007-04 |
| Est. Completion | 2014-02 |
What the finished NCT00774137 record still lists
NCT00774137 is an observational study that tracks outcomes without assigning an intervention. Its 1,550 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00774137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00774137 about?
NCT00774137 is a clinical study titled "Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery". People who undergo coronary artery bypass grafting (CABG) or heart valve surgery may experience acute kidney injury (AKI) after their surgery. Current medical tests cannot identify AKI until approximately 48 hours after it occurs. This study will examine three new biomarkers in blood and urine that ...
What is the current status of trial NCT00774137?
This trial is currently completed. The enrollment target is 1,550 participants. The study started on 2007-04. Estimated completion is 2014-02.
Who is sponsoring clinical trial NCT00774137?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia